Stay updated on Zimberelimab Combo vs Pembrolizumab with Chemo in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Zimberelimab Combo vs Pembrolizumab with Chemo in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Zimberelimab Combo vs Pembrolizumab with Chemo in NSCLC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The page revision updated from v3.4.1 to v3.4.2, a minor technical update that does not affect study details or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-12T05:39:04.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The study's location count was updated to 186 with the release of revision 3.4.1. Numerous sites and contact details have been removed or withdrawn.
    Difference
    5%
    Check dated 2026-02-05T04:27:55.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    A glossary toggle has been added to the page header, and the footer now shows 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0', replacing the previous wording and version. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-28T23:46:34.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Recruitment status updated to Recruiting as of 2026-01-15, replacing the previous Active, not recruiting status and adding the update timestamps (Last Update Posted 2026-01-14 and 2026-01-15).
    Difference
    0.3%
    Check dated 2026-01-21T19:35:39.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Locations sections were expanded to include multiple states (Arizona, California, Connecticut, District of Columbia, Florida, Georgia, Illinois, North Carolina, Ohio, Oregon, Pennsylvania, Texas, Virginia, and Washington) and the HHS Vulnerability Disclosure link was removed, with the revision updated to v3.3.3.
    Difference
    0.5%
    Check dated 2025-12-23T08:19:31.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    These changes appear to be metadata-level updates, including a new revision tag (v3.3.2) and revised timestamps, with no impact on core study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2025-12-01T17:50:00.000Z thumbnail image

Stay in the know with updates to Zimberelimab Combo vs Pembrolizumab with Chemo in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Zimberelimab Combo vs Pembrolizumab with Chemo in NSCLC Clinical Trial page.